These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28039670)

  • 1. Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.
    Nardelli S; Allampati S; Riggio O; Mullen KD; Prakash R; Gioia S; Unser A; White MB; Fagan AC; Wade JB; Farcomeni A; Gavis EA; Bajaj JS
    Dig Dis Sci; 2017 Mar; 62(3):794-800. PubMed ID: 28039670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
    Umapathy S; Dhiman RK; Grover S; Duseja A; Chawla YK
    Am J Gastroenterol; 2014 Jul; 109(7):1011-9. PubMed ID: 24777152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the inhibitory control task to detect minimal hepatic encephalopathy.
    Amodio P; Ridola L; Schiff S; Montagnese S; Pasquale C; Nardelli S; Pentassuglio I; Trezza M; Marzano C; Flaiban C; Angeli P; Cona G; Bisiacchi P; Gatta A; Riggio O
    Gastroenterology; 2010 Aug; 139(2):510-8, 518.e1-2. PubMed ID: 20470775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: the modern management of hepatic encephalopathy.
    Bajaj JS
    Aliment Pharmacol Ther; 2010 Mar; 31(5):537-47. PubMed ID: 20002027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
    Kircheis G; Hilger N; Häussinger D
    Gastroenterology; 2014 Apr; 146(4):961-9. PubMed ID: 24365582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.
    Ahluwalia V; Wade JB; Thacker L; Kraft KA; Sterling RK; Stravitz RT; Fuchs M; Bouneva I; Puri P; Luketic V; Sanyal AJ; Gilles H; Heuman DM; Bajaj JS
    J Hepatol; 2013 Sep; 59(3):467-73. PubMed ID: 23665182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study.
    Wunsch E; Koziarska D; Kotarska K; Nowacki P; Milkiewicz P
    Liver Int; 2013 Oct; 33(9):1332-40. PubMed ID: 23651263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J; Sharma BC; Maharshi S; Puri V; Srivastava S
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study.
    Bajaj JS; Riggio O; Allampati S; Prakash R; Gioia S; Onori E; Piazza N; Noble NA; White MB; Mullen KD
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1511-6. PubMed ID: 23707462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective comparative study of inhibitory control test and psychometric hepatic encephalopathy score for diagnosis and prognosis of minimal hepatic encephalopathy in cirrhotic patients in the Indian subcontinent.
    Gupta D; Ingle M; Shah K; Phadke A; Sawant P
    J Dig Dis; 2015 Jul; 16(7):400-7. PubMed ID: 25858627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
    Seo YS; Yim SY; Jung JY; Kim CH; Kim JD; Keum B; An H; Yim HJ; Lee HS; Kim CD; Ryu HS; Um SH
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1695-704. PubMed ID: 22743001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.
    Irimia R; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1021-7. PubMed ID: 23700882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy.
    Duarte-Rojo A; Estradas J; Hernández-Ramos R; Ponce-de-León S; Córdoba J; Torre A
    Dig Dis Sci; 2011 Oct; 56(10):3014-23. PubMed ID: 21461913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
    Bajaj JS; Schubert CM; Heuman DM; Wade JB; Gibson DP; Topaz A; Saeian K; Hafeezullah M; Bell DE; Sterling RK; Stravitz RT; Luketic V; White MB; Sanyal AJ
    Gastroenterology; 2010 Jun; 138(7):2332-40. PubMed ID: 20178797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.